Advertisement
Advertisement

MNOV

MNOV logo

Medicinova Inc

1.92
USD
+0.11
+6.08%
Jan 23, 15:57 UTC -5
Open

Medicinova Inc Profile

About

MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova's pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancers, Generalized Anxiety Disorder, preterm labor and urinary incontinence and twopreclinical-stage compounds for the treatment of thrombotic disorders. MediciNova will seek to monetize its other product candidates at key value inflection points.

Info & Links

CEO

Yuichi Iwaki

Headquarters

4275 EXECUTIVE SQUARE, SUITE 300
LA JOLLA, CA 92037, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.medicinova.com

Auditor

BDO USA, P.C.

Share holders

11

Employees

13

Medicinova Inc Statistics

Valuation Measures

Market Capitalization2

94.18M

Enterprise Value

51.90M

Enterprise Value/EBITDA(ttm)

-4.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-17.55%

Return on Invested Capital(ttm)

-17.65%

Return on Assets(ttm)

-16.62%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.96M

Net Income Available to Common(ttm)

-10.29M

Diluted EPS(ttm)

-0.21

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

10.34%

S&P 500 52-Week Change

25.41%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

49.05M

Dividend Yield

0.00%

Float4

41.74M

% Held by Insiders

14.90%

% Held by Institutions

9.90%

Balance Sheet

Total Cash(mrq)

42.28M

Total Cash Per Share(mrq)

0.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.66%

Quick Ratio(mrq)

16.66%

Book Value Per Share(mrq)

1.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.18

Free Cash Flow(ytd)

-8.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement